You’ll navigate Medicare Part D by knowing its three phases: deductible, initial coverage, and catastrophic. In 2025, you’ll pay up to a $590 deductible, then typically 25% coinsurance until your true out-of-pocket hits $2,000—after that, covered drugs cost $0. Insulin copays are capped at $35/month in many plans. Big reforms aim to lower America’s unusually high drug prices, with Medicare negotiations starting in 2026. You’ll also see how plans, PBMs, and manufacturers shape costs—and what to do next.
Important Factors
- Medicare Part D has three phases: deductible (up to $590), initial coverage (25% coinsurance), and catastrophic ($0 after $2,100 out-of-pocket in 2026).
- Reaching $2,100 in true out-of-pocket costs triggers catastrophic coverage with no further cost for covered drugs for the year.
- Insulin copays are capped at $35 per month in participating plans, improving affordability for many beneficiaries.
- Drug price reforms include Medicare’s new negotiation authority, with first negotiated prices expected in 2026 and reductions of roughly 38–79% on select drugs.
- U.S. drug prices are far higher than abroad; international benchmarking and “most favored nation” concepts aim to lower prices substantially.
How Part D Coverage Works: Deductible, Initial Coverage, and Catastrophic Phases
Even if Part D feels complex at first, its coverage follows three clear phases: deductible, initial coverage, and catastrophic.
You start in the deductible phase, when you pay the plan’s full allowed cost for covered drugs until you meet your plan’s deductible.
After that, you enter initial coverage, where the plan shares costs with you using standard cost-sharing rules and its formulary tiers. Your spending on covered drugs then accumulates toward a fixed out-of-pocket threshold.
Once you reach that threshold, you move into the catastrophic phase, where your covered prescriptions are fully protected and you pay nothing for the rest of the year.
What You Pay in Each Phase and 2026 Cost Thresholds
While the phases stay the same, what you pay changes at each step and 2026 sets clear dollar markers.
First, you face the deductible: you pay 100% of drug costs until you meet your plan’s deductible, up to $590.
Next, in initial coverage, you typically pay 25% co-insurance on medications after the deductible. For brand drugs, plans cover about 65% and Medicare covers 10%.
Finally, once your true out-of-pocket costs reach $2,000, you enter catastrophic coverage and pay $0 for the rest of 2025.
Track your spending, use preferred pharmacies, and review plan details to match these thresholds.
Drug Pricing Landscape and the Push for International Benchmarking
After you understand what you pay in each Part D phase, the bigger question is why drugs cost so much in the U.S. compared with other countries.
You’ve likely seen stark price gaps: Ozempic averages $936 monthly here versus $169 in Japan and under $100 in the U.K., Australia, and France.
A RAND study shows Americans pay nearly triple overall.
International benchmarking aims to narrow that gap. A “most favored nation” concept would peg U.S. prices to the lowest among peer nations, potentially cutting certain drug costs by 50–90%.
Upcoming Medicare negotiation authority also targets high-cost drugs, with sizable reductions expected starting in 2026.
Stakeholders Shaping Part D: Plans, PBMs, Medicare, and Manufacturers
Though Part D looks like a single benefit, four players shape what you pay and what’s covered. You enroll in a Part D plan that designs formularies, tiers, and prior authorizations, steering you toward preferred drugs and pharmacies.
PBMs negotiate rebates and discounts with manufacturers, then set formularies and pharmacy networks for plans. Medicare sets rules, phases, and actuarial standards, approves formularies, and subsidizes plan liability.
Manufacturers set list prices, offer coupons outside Part D, and fund rebates that influence tiers.
You feel this at the counter: tier placement, deductibles, 25% coinsurance, pharmacy choice, and utilization rules determine your costs across the benefit.
Recent Policy Changes: Insulin Caps, Catastrophic $0 Cost Sharing, and Negotiations
Even if your drugs haven’t changed, new Part D rules will change what you pay. In 2025, once you’ve spent $2,000 on covered drugs, you’ll enter catastrophic coverage and pay $0 for the rest of the year.
If you use insulin, participating plans cap many insulin copays at $35 per month.
You’ll also see Medicare’s new price negotiations start phasing in. The Inflation Reduction Act lets Medicare negotiate high-cost drugs, with initial negotiated prices expected in 2026 and potential reductions of roughly 38–79% on selected medications.
Keep an eye on which drugs get chosen and how your plan applies these changes to your costs.
Premium Trends and What Savings May Mean for You
Those policy changes shape what you pay at the counter, but your monthly premium matters too. Part D premiums have stayed relatively stable over two decades, rising from about $26 in 2006 to roughly $45 projected in 2025, with plans ranging from $0 to about $133.
Savings from negotiated prices and insulin caps may lower overall spending, but it’s uncertain how much will flow into premiums versus federal savings.
- Premiums reflect plan design: formularies, tiers, and pharmacy networks drive variability.
- Lower premiums don’t guarantee lower total costs if your drugs sit on higher tiers.
- Catastrophic $0 cost sharing shifts risk back to plans, pressuring premiums differently across markets.
Smart Steps for Beneficiaries During Annual Enrollment and Beyond
As you head into Annual Enrollment (Oct 15–Dec 7), focus on three moves: confirm your meds are on each plan’s formulary and tier, price them at your preferred pharmacies, and compare total annual costs—not just premiums.
Check deductible amounts, copays, and coinsurance through each phase. If you use insulin, verify $35 caps. Run your drugs on Medicare’s Plan Finder, toggling pharmacies and mail order. Favor plans where your pharmacy is “preferred.”
If you expect high spending, note the $2,100 cap in 2026. Apply for Extra Help at ssa.gov if eligible.
Print your med list and formulary for doctor visits. Recheck midyear changes and ask about generics.
Frequently Asked Questions
How Do Prior Authorizations and Step Therapy Affect Access to Drugs?
They delay access by requiring insurer approval or trying cheaper drugs first. You face paperwork, denials, and appeals. Doctors justify need; plans may mandate step therapy tiers. You can request exceptions, cite failures, and escalate grievances to expedite coverage.
Can I Use Manufacturer Copay Cards With Part D Coverage?
No. You generally can’t use manufacturer copay cards with Part D. They’re barred for federal programs. Instead, compare plans, use preferred pharmacies, ask about generics, apply for Extra Help, or seek manufacturer patient assistance programs.
What Happens if I Travel or Move States Midyear With Part D?
You keep coverage while traveling; use in-network pharmacies. If you move, you trigger a Special Enrollment Period: update address, compare plans, switch within time limits, avoid gaps. Notify your plan, confirm formulary, pharmacy access, and costs at your new ZIP.
How Do Specialty Tiers Differ From Other Formulary Tiers?
Specialty tiers contain very high-cost drugs and usually require higher coinsurance, prior authorization, or step therapy. You’ll often pay a percentage instead of a copay, face limited exceptions, and encounter restricted pharmacies or specialty handling requirements.
How Are Mail-Order Pharmacies Treated Versus Retail in Part D?
Mail-order and retail are treated similarly for coverage, but you’ll often get 90‑day mail fills at lower copays from preferred pharmacies. Verify preferred status, shipping times, and refill rules. Need predictable costs and convenience? Mail‑order usually wins.